Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
110772022 | 11077202 | 2 | F | 20160725 | 20160810 | 20150429 | 20160822 | EXP | US-ACTELION-A-US2015-116841 | ACTELION | 64.00 | YR | A | F | Y | 0.00000 | 20160822 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
110772022 | 11077202 | 1 | PS | VELETRI | EPOPROSTENOL | 1 | Intravenous (not otherwise specified) | 43 NG/KG, PER MIN | 22260 | INJECTION | /min | ||||||||
110772022 | 11077202 | 2 | SS | REVATIO | SILDENAFIL CITRATE | 1 | 20 MG, TID | U | U | 0 | 20 | MG | TID | ||||||
110772022 | 11077202 | 3 | C | PREDNISONE. | PREDNISONE | 1 | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
110772022 | 11077202 | 1 | Pulmonary arterial hypertension |
110772022 | 11077202 | 2 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
110772022 | 11077202 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
110772022 | 11077202 | Clostridium difficile infection | |
110772022 | 11077202 | Nausea | |
110772022 | 11077202 | Protein-losing gastroenteropathy |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
110772022 | 11077202 | 1 | 20150123 | 0 |